Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) hit a new 52-week high on Monday . The company traded as high as GBX 1,723.20 ($21.04) and last traded at GBX 1,723.20 ($21.04), with a volume of 519 shares traded. The stock had previously closed at GBX 1,702.60 ($20.79).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The firm has a market cap of £5.20 billion and a P/E ratio of -1,598.91. The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of GBX 1,656.09 and a two-hundred day moving average of GBX 1,593.16.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- The Role Economic Reports Play in a Successful Investment Strategy
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What is a Special Dividend?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Golden Cross Stocks: Pattern, Examples and Charts
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
